The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neuroscience Antibodies and Assays Technology Market Research Report 2025
Synopsis
Neuroscience antibodies and assays technology refers to the specialized tools and techniques used in neuroscience research to study and analyze proteins, biomolecules, and cellular processes in the nervous system. These technologies play a crucial role in understanding the complexities of the brain and its functions, including neuronal communication, synaptic signaling, and the underlying molecular mechanisms of neurological diseases and disorders.
The global Neuroscience Antibodies and Assays Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global market for neuroscience antibodies and assays technology has been witnessing substantial growth due to the increasing research activities in neuroscience, the rising prevalence of neurological disorders, and the advancements in life science technologies. Neuroscience antibodies and assays play a crucial role in understanding the complexities of the nervous system and exploring potential therapeutic targets for neurological diseases. The market for neuroscience antibodies and assays technology is significant in regions with strong research and healthcare infrastructures. North America, including the United States, has been a major contributor to the market due to its large base of research institutions and pharmaceutical companies focused on neuroscience. Europe and Asia-Pacific regions have also witnessed substantial growth in neuroscience research, driving the demand for neuroscience antibodies and assays technology.
This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays Technology.
Report Scope
The Neuroscience Antibodies and Assays Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroscience Antibodies and Assays Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroscience Antibodies and Assays Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
BioLegend
Siemens
Bio-Rad
Genscript Biotech
Rockland Immunochemicals
Cell Signaling Technology
Merck
Tecan Group
Santa Cruz Biotechnology
Thermo Fisher Scientific
Enzo Life Sciences
Segment by Type
Molecular Diagnostics
Clinical Chemistry
Immunoassay
Immunochemistry
Others
Segment by Application
Hospitals
Diagnostics Center
Pharmaceutical and Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neuroscience antibodies and assays technology refers to the specialized tools and techniques used in neuroscience research to study and analyze proteins, biomolecules, and cellular processes in the nervous system. These technologies play a crucial role in understanding the complexities of the brain and its functions, including neuronal communication, synaptic signaling, and the underlying molecular mechanisms of neurological diseases and disorders.
The global Neuroscience Antibodies and Assays Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global market for neuroscience antibodies and assays technology has been witnessing substantial growth due to the increasing research activities in neuroscience, the rising prevalence of neurological disorders, and the advancements in life science technologies. Neuroscience antibodies and assays play a crucial role in understanding the complexities of the nervous system and exploring potential therapeutic targets for neurological diseases. The market for neuroscience antibodies and assays technology is significant in regions with strong research and healthcare infrastructures. North America, including the United States, has been a major contributor to the market due to its large base of research institutions and pharmaceutical companies focused on neuroscience. Europe and Asia-Pacific regions have also witnessed substantial growth in neuroscience research, driving the demand for neuroscience antibodies and assays technology.
This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays Technology.
Report Scope
The Neuroscience Antibodies and Assays Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroscience Antibodies and Assays Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroscience Antibodies and Assays Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
BioLegend
Siemens
Bio-Rad
Genscript Biotech
Rockland Immunochemicals
Cell Signaling Technology
Merck
Tecan Group
Santa Cruz Biotechnology
Thermo Fisher Scientific
Enzo Life Sciences
Segment by Type
Molecular Diagnostics
Clinical Chemistry
Immunoassay
Immunochemistry
Others
Segment by Application
Hospitals
Diagnostics Center
Pharmaceutical and Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Molecular Diagnostics
1.2.3 Clinical Chemistry
1.2.4 Immunoassay
1.2.5 Immunochemistry
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostics Center
1.3.4 Pharmaceutical and Biotechnology Company
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Technology Market Perspective (2019-2030)
2.2 Neuroscience Antibodies and Assays Technology Growth Trends by Region
2.2.1 Global Neuroscience Antibodies and Assays Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neuroscience Antibodies and Assays Technology Historic Market Size by Region (2019-2024)
2.2.3 Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2025-2030)
2.3 Neuroscience Antibodies and Assays Technology Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Technology Industry Trends
2.3.2 Neuroscience Antibodies and Assays Technology Market Drivers
2.3.3 Neuroscience Antibodies and Assays Technology Market Challenges
2.3.4 Neuroscience Antibodies and Assays Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue (2019-2024)
3.1.2 Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Players (2019-2024)
3.2 Global Neuroscience Antibodies and Assays Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Technology Revenue
3.4 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Technology Revenue in 2023
3.5 Neuroscience Antibodies and Assays Technology Key Players Head office and Area Served
3.6 Key Players Neuroscience Antibodies and Assays Technology Product Solution and Service
3.7 Date of Enter into Neuroscience Antibodies and Assays Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Technology Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Type (2019-2024)
4.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2025-2030)
5 Neuroscience Antibodies and Assays Technology Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Application (2019-2024)
5.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neuroscience Antibodies and Assays Technology Market Size (2019-2030)
6.2 North America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024)
6.4 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Technology Market Size (2019-2030)
7.2 Europe Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024)
7.4 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size (2019-2030)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Technology Market Size (2019-2030)
9.2 Latin America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024)
9.4 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size (2019-2030)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Neuroscience Antibodies and Assays Technology Introduction
11.1.4 Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 BioLegend
11.2.1 BioLegend Company Detail
11.2.2 BioLegend Business Overview
11.2.3 BioLegend Neuroscience Antibodies and Assays Technology Introduction
11.2.4 BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.2.5 BioLegend Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens Neuroscience Antibodies and Assays Technology Introduction
11.3.4 Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.3.5 Siemens Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Detail
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Neuroscience Antibodies and Assays Technology Introduction
11.4.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.4.5 Bio-Rad Recent Development
11.5 Genscript Biotech
11.5.1 Genscript Biotech Company Detail
11.5.2 Genscript Biotech Business Overview
11.5.3 Genscript Biotech Neuroscience Antibodies and Assays Technology Introduction
11.5.4 Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.5.5 Genscript Biotech Recent Development
11.6 Rockland Immunochemicals
11.6.1 Rockland Immunochemicals Company Detail
11.6.2 Rockland Immunochemicals Business Overview
11.6.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Introduction
11.6.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.6.5 Rockland Immunochemicals Recent Development
11.7 Cell Signaling Technology
11.7.1 Cell Signaling Technology Company Detail
11.7.2 Cell Signaling Technology Business Overview
11.7.3 Cell Signaling Technology Neuroscience Antibodies and Assays Technology Introduction
11.7.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.7.5 Cell Signaling Technology Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Neuroscience Antibodies and Assays Technology Introduction
11.8.4 Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Tecan Group
11.9.1 Tecan Group Company Detail
11.9.2 Tecan Group Business Overview
11.9.3 Tecan Group Neuroscience Antibodies and Assays Technology Introduction
11.9.4 Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.9.5 Tecan Group Recent Development
11.10 Santa Cruz Biotechnology
11.10.1 Santa Cruz Biotechnology Company Detail
11.10.2 Santa Cruz Biotechnology Business Overview
11.10.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Introduction
11.10.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.10.5 Santa Cruz Biotechnology Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Detail
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Introduction
11.11.4 Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Enzo Life Sciences
11.12.1 Enzo Life Sciences Company Detail
11.12.2 Enzo Life Sciences Business Overview
11.12.3 Enzo Life Sciences Neuroscience Antibodies and Assays Technology Introduction
11.12.4 Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024)
11.12.5 Enzo Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Molecular Diagnostics
Table 3. Key Players of Clinical Chemistry
Table 4. Key Players of Immunoassay
Table 5. Key Players of Immunochemistry
Table 6. Key Players of Others
Table 7. Global Neuroscience Antibodies and Assays Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Neuroscience Antibodies and Assays Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Neuroscience Antibodies and Assays Technology Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2019-2024)
Table 11. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2025-2030)
Table 13. Neuroscience Antibodies and Assays Technology Market Trends
Table 14. Neuroscience Antibodies and Assays Technology Market Drivers
Table 15. Neuroscience Antibodies and Assays Technology Market Challenges
Table 16. Neuroscience Antibodies and Assays Technology Market Restraints
Table 17. Global Neuroscience Antibodies and Assays Technology Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Neuroscience Antibodies and Assays Technology Market Share by Players (2019-2024)
Table 19. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2023)
Table 20. Ranking of Global Top Neuroscience Antibodies and Assays Technology Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Technology Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neuroscience Antibodies and Assays Technology Product Solution and Service
Table 24. Date of Enter into Neuroscience Antibodies and Assays Technology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroscience Antibodies and Assays Technology Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2019-2024)
Table 28. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2025-2030)
Table 30. Global Neuroscience Antibodies and Assays Technology Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2019-2024)
Table 32. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2025-2030)
Table 34. North America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abcam Company Detail
Table 50. Abcam Business Overview
Table 51. Abcam Neuroscience Antibodies and Assays Technology Product
Table 52. Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 53. Abcam Recent Development
Table 54. BioLegend Company Detail
Table 55. BioLegend Business Overview
Table 56. BioLegend Neuroscience Antibodies and Assays Technology Product
Table 57. BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 58. BioLegend Recent Development
Table 59. Siemens Company Detail
Table 60. Siemens Business Overview
Table 61. Siemens Neuroscience Antibodies and Assays Technology Product
Table 62. Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 63. Siemens Recent Development
Table 64. Bio-Rad Company Detail
Table 65. Bio-Rad Business Overview
Table 66. Bio-Rad Neuroscience Antibodies and Assays Technology Product
Table 67. Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 68. Bio-Rad Recent Development
Table 69. Genscript Biotech Company Detail
Table 70. Genscript Biotech Business Overview
Table 71. Genscript Biotech Neuroscience Antibodies and Assays Technology Product
Table 72. Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 73. Genscript Biotech Recent Development
Table 74. Rockland Immunochemicals Company Detail
Table 75. Rockland Immunochemicals Business Overview
Table 76. Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Product
Table 77. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 78. Rockland Immunochemicals Recent Development
Table 79. Cell Signaling Technology Company Detail
Table 80. Cell Signaling Technology Business Overview
Table 81. Cell Signaling Technology Neuroscience Antibodies and Assays Technology Product
Table 82. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 83. Cell Signaling Technology Recent Development
Table 84. Merck Company Detail
Table 85. Merck Business Overview
Table 86. Merck Neuroscience Antibodies and Assays Technology Product
Table 87. Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Tecan Group Company Detail
Table 90. Tecan Group Business Overview
Table 91. Tecan Group Neuroscience Antibodies and Assays Technology Product
Table 92. Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 93. Tecan Group Recent Development
Table 94. Santa Cruz Biotechnology Company Detail
Table 95. Santa Cruz Biotechnology Business Overview
Table 96. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Product
Table 97. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 98. Santa Cruz Biotechnology Recent Development
Table 99. Thermo Fisher Scientific Company Detail
Table 100. Thermo Fisher Scientific Business Overview
Table 101. Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Product
Table 102. Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 103. Thermo Fisher Scientific Recent Development
Table 104. Enzo Life Sciences Company Detail
Table 105. Enzo Life Sciences Business Overview
Table 106. Enzo Life Sciences Neuroscience Antibodies and Assays Technology Product
Table 107. Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2019-2024) & (US$ Million)
Table 108. Enzo Life Sciences Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroscience Antibodies and Assays Technology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Neuroscience Antibodies and Assays Technology Market Share by Type: 2023 VS 2030
Figure 3. Molecular Diagnostics Features
Figure 4. Clinical Chemistry Features
Figure 5. Immunoassay Features
Figure 6. Immunochemistry Features
Figure 7. Others Features
Figure 8. Global Neuroscience Antibodies and Assays Technology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Neuroscience Antibodies and Assays Technology Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Diagnostics Center Case Studies
Figure 12. Pharmaceutical and Biotechnology Company Case Studies
Figure 13. Others Case Studies
Figure 14. Neuroscience Antibodies and Assays Technology Report Years Considered
Figure 15. Global Neuroscience Antibodies and Assays Technology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Neuroscience Antibodies and Assays Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Neuroscience Antibodies and Assays Technology Market Share by Region: 2023 VS 2030
Figure 18. Global Neuroscience Antibodies and Assays Technology Market Share by Players in 2023
Figure 19. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Technology Revenue in 2023
Figure 21. North America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Neuroscience Antibodies and Assays Technology Market Share by Country (2019-2030)
Figure 23. United States Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Neuroscience Antibodies and Assays Technology Market Share by Country (2019-2030)
Figure 27. Germany Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Share by Region (2019-2030)
Figure 35. China Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Neuroscience Antibodies and Assays Technology Market Share by Country (2019-2030)
Figure 43. Mexico Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Share by Country (2019-2030)
Figure 47. Turkey Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 50. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 51. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 52. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 53. Genscript Biotech Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 54. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 55. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 57. Tecan Group Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 58. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 60. Enzo Life Sciences Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
